Physician profile
Sara Burnbaum
NPI 1285076695
$1,958.62
in general payments reported to CMS, 2019-2025
13 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.08 · 2022: $592 · 2023: $410 · 2024: $457 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $398.11 | 2021-2024 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $364.14 | 2022-2025 | Arexvy, Shingrix, Bexsero |
| Boehringer Ingelheim Pharmaceuticals, INC. | $312.32 | 2021-2025 | Jardiance |
| Pfizer INC. | $299.38 | 2021-2025 | |
| Exact Sciences Corporation | $219.10 | 2023-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $112.29 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $106.09 | 2023-2025 | |
| Evoke Pharma, INC. | $54.03 | 2022 | |
| Seqirus USA INC | $22.67 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Lilly USA, LLC | $20.17 | 2023 | Jardiance |
| Insulet Corporation | $17.34 | 2025 | Omnipod |
| Medtronic, INC. | $17.07 | 2023 | Minimed 780g |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Burnbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.